Specialty Pharma Journal Specialty, Precision & Technology

PHILADELPHIA and HOUSTON, United States and OXFORD, United Kingdom, Sept. 26, 2016 (GLOBE NEWSWIRE) — …

PR Newswire, Horsham, Pa., September 26, 2016 — Janssen Biotech, Inc., announced today that the …

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced that, after an extensive evaluation, the company’s Board of …

London, UK; 26 Sept 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: “GWP,” “GW,” “the Company” …

Basel, September 23, 2016 – Novartis announced today that the US Food and Drug Administration …

THOUSAND OAKS, Calif., Sept. 23, 2016 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food …

Cancer treatment and depression go hand-in-hand. In fact, this belief was previously so entrenched in …

MAINZ, Germany, September 21, 2016 /PRNewswire/ –BioNTech AG, a fully integrated private biotechnology company developing …

RARITAN, N.J., Sept. 21, 2016 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) announced today the U.S. …

DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading …

CAMBRIDGE, Mass. & TORONTO–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) and Viventia Bio Inc., today announced …

LOS ANGELES, Calif., Sept. 20, 2016 – Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, …

“These steps will improve the safety, accessibility and impact of our clinical research system. They …

Basel, September 17, 2016 – Novartis today announced positive results of the Phase III EXPAND …

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced the confirmatory study (REFLECTIONS B537-02) evaluating the efficacy, safety, …